Delving into the Latest Updates on DWJ-1609 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Daewoong Pharmaceutical Co., Ltd.

Active Organization

Daewoong Pharmaceutical Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

Phase of Development : III
Sponsor : DAEWOONG PHARMACEUTICAL
Study Sites and Principal Investigator : Dong ll Park M.D. Ph.D , Gastroenterology Kangbuk Samsung Hospital and other 6 study sites
Study Period : From the protocol approval date (institutional review board, IRB) 24 Months
Investigational product :
Investigational Products DWJ1609 (sodium sulfate potassium sulfate, Magnesium Sulfate Anhydrous , simethicone, sodium picosulphate)
Control Products DWC202304 (sodium sulfate potassium sulfate, Magnesium Sulfate Anhydrous , simethicone)
Target Diseases : A person who needs treatment before colonoscopy (X-ray, endoscopy)
Number of Subjects : 214 Subjects in total (85 subjects per group, 2 groups in total, considering a 20% dropout rate)

Start Date08 Mar 2024

Sponsor / Collaborator

Daewoong Pharmaceutical Co., Ltd.

100 Clinical Results associated with DWJ-1609

Login to view more data

100 Translational Medicine associated with DWJ-1609

Login to view more data

100 Patents (Medical) associated with DWJ-1609

Login to view more data

100 Deals associated with DWJ-1609

Login to view more data